跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VISUBLEND 0,3 MG/ML + 5 MG/ML COLIRIO EN SOLUCION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VISUBLEND 0,3 MG/ML + 5 MG/ML COLIRIO EN SOLUCION
Approved
STANDARD
VISUBLEND 0,3 MG/ML + 5 MG/ML COLIRIO EN SOLUCION
Visufarma S.P.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 21, 2022
Approval ID
6f19606577069963
Company
Visufarma S.P.A.
Type
Standard
Approval Details
Approval Id
6f19606577069963
Drug Cima Aemps Name
VISUBLEND 0,3 MG/ML + 5 MG/ML COLIRIO EN SOLUCION
Register Number
86416
Holder Company Name
Visufarma S.P.A.
Marketing Company Name
Visufarma S.P.A.
Authorization Date
2022-04-21
Dosage Form
COLIRIO EN SOLUCIÓN
Dose
0,3 MG/ML + 5 MG/ML
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Visufarma S.P.A.
Active Ingredients
BIMATOPROST
0,3 mg/ml
TIMOLOL MALEATO
6,83 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 21, 2022
Approval ID
6f19606577069963
Type
Standard
Back to CIMA-AEMPS Approvals
